Verismo Therapeutics Competitors and Similar CompaniesClear all
Verismo Therapeutics's competitors and similar companies include Medicenna Therapeutics, AsclepiX Therapeutics, Nkarta Therapeutics and Lyell.
 Verismo Therapeutics Verismo Therapeutics is a company that develops a KIR-CAR platform for cancer treatment. |  AsclepiX Therapeutics AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform. |  Nkarta Therapeutics Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer. | |||
Founding Date | Founding Date 2020 | Founding Date 2012 | Founding Date 2011 | Founding Date 2015 | Founding Date 2018 |
Type | Type Private | Type Public | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Philadelphia, US HQ | Locations HQ | Locations Baltimore, US HQ Jersey City, US | Locations South San Francisco, US HQ | Locations South San Francisco, US HQ Bothell, US Seattle, US |
Employees | Employees 28 | Employees 7 | Employees 7 | Employees 1594% decrease | Employees 188 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 122.2 m | Valuation ($) N/A | Valuation ($) 240.6 m | Valuation ($) 243.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $36k (FY, 2025) |
Net income | Net income N/A | Net income ($11.8m) (FY, 2025) | Net income N/A | Net income ($104.1m) (FY, 2025) | Net income ($274.4m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 7.5m | Total funding raised $ 40m | Total funding raised $ 125m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Medicenna Therapeutics
HQ
Employees
7
Medicenna Therapeutics is an immunotherapy company focused on oncology.
View companyAsclepiX Therapeutics
HQ
Baltimore, US
Employees
7
AsclepiX Therapeutics is a biopharmaceutical company which focuses on therapies based on a peptide platform.
View companyNkarta Therapeutics
HQ
South San Francisco, US
Employees
159↓ 4% decrease
Nkarta Therapeutics is a biopharmaceutical company developing engineered natural killer (NK) cell therapies for the treatment of cancer.
View company
Lyell
HQ
South San Francisco, US
Employees
188
Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.
View company